Robert Burns
Stock Analyst at HC Wainwright & Co.
(0.99)
# 3,568
Out of 4,711 analysts
464
Total ratings
25.18%
Success rate
-17.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADCT ADC Therapeutics | Reiterates: Buy | n/a | $1.96 | - | 19 | Dec 11, 2024 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $30 → $35 | $19.83 | +76.50% | 13 | Dec 11, 2024 | |
| YMAB Y-mAbs Therapeutics | Reiterates: Buy | n/a | $8.28 | - | 18 | Dec 11, 2024 | |
| COGT Cogent Biosciences | Reiterates: Buy | n/a | $7.84 | - | 9 | Dec 11, 2024 | |
| BCAX Bicara Therapeutics | Initiates: Buy | $42 | $17.59 | +138.77% | 1 | Dec 6, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $64 → $72 | $44.06 | +63.41% | 18 | Dec 4, 2024 | |
| RLAY Relay Therapeutics | Maintains: Buy | $20 → $16 | $4.16 | +284.62% | 19 | Dec 4, 2024 | |
| REPL Replimune Group | Reiterates: Buy | $17 | $12.49 | +36.11% | 14 | Nov 22, 2024 | |
| ZYME Zymeworks | Reiterates: Neutral | $12 | $14.14 | -15.13% | 19 | Nov 22, 2024 | |
| BNTX BioNTech SE | Reiterates: Buy | $150 | $113.08 | +32.65% | 37 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $26.09 | +37.98% | 6 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $14.90 | +121.48% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.80 | +400.00% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $74 | $35.59 | +107.92% | 28 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.38 | +377.33% | 2 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $3.10 | +319.35% | 11 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.87 | +381.28% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.30 | +284.62% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.32 | +657.58% | 17 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $3.18 | +25.79% | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.22 | +395.50% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $8.21 | +155.79% | 17 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.17 | +222.58% | 5 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $22.47 | +64.66% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $33.29 | -12.89% | 3 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.68 | +161.19% | 11 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $6.90 | +59.42% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.88 | +104.92% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.39 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $11.40 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.50 | +233.33% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.96 | +134.89% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $0.84 | +1,333.86% | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $9.75 | +1,951.28% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.21 | +1,804.76% | 8 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $1.36 | +1,370.59% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.96 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.75 | +8,495.99% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.55 | +1,319.35% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.68 | +316.67% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $1.09 | +909.17% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $1.21 | +18,495.04% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $5.08 | +392.13% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $2.29 | +467.69% | 1 | Jan 7, 2021 |
ADC Therapeutics
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $1.96
Upside: -
Nurix Therapeutics
Dec 11, 2024
Maintains: Buy
Price Target: $30 → $35
Current: $19.83
Upside: +76.50%
Y-mAbs Therapeutics
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $8.28
Upside: -
Cogent Biosciences
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $7.84
Upside: -
Bicara Therapeutics
Dec 6, 2024
Initiates: Buy
Price Target: $42
Current: $17.59
Upside: +138.77%
Revolution Medicines
Dec 4, 2024
Maintains: Buy
Price Target: $64 → $72
Current: $44.06
Upside: +63.41%
Relay Therapeutics
Dec 4, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $4.16
Upside: +284.62%
Replimune Group
Nov 22, 2024
Reiterates: Buy
Price Target: $17
Current: $12.49
Upside: +36.11%
Zymeworks
Nov 22, 2024
Reiterates: Neutral
Price Target: $12
Current: $14.14
Upside: -15.13%
BioNTech SE
Nov 18, 2024
Reiterates: Buy
Price Target: $150
Current: $113.08
Upside: +32.65%
Nov 15, 2024
Reiterates: Buy
Price Target: $36
Current: $26.09
Upside: +37.98%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $14.90
Upside: +121.48%
Nov 15, 2024
Reiterates: Buy
Price Target: $9
Current: $1.80
Upside: +400.00%
Nov 12, 2024
Maintains: Buy
Price Target: $76 → $74
Current: $35.59
Upside: +107.92%
Nov 8, 2024
Reiterates: Buy
Price Target: $40
Current: $8.38
Upside: +377.33%
Nov 8, 2024
Reiterates: Buy
Price Target: $13
Current: $3.10
Upside: +319.35%
Nov 8, 2024
Reiterates: Buy
Price Target: $9
Current: $1.87
Upside: +381.28%
Nov 8, 2024
Reiterates: Buy
Price Target: $5
Current: $1.30
Upside: +284.62%
Nov 8, 2024
Reiterates: Buy
Price Target: $10
Current: $1.32
Upside: +657.58%
Nov 6, 2024
Reiterates: Neutral
Price Target: $4
Current: $3.18
Upside: +25.79%
Nov 6, 2024
Reiterates: Buy
Price Target: $11
Current: $2.22
Upside: +395.50%
Nov 4, 2024
Reiterates: Buy
Price Target: $21
Current: $8.21
Upside: +155.79%
Oct 3, 2024
Reiterates: Buy
Price Target: $7
Current: $2.17
Upside: +222.58%
Oct 1, 2024
Reiterates: Buy
Price Target: $37
Current: $22.47
Upside: +64.66%
Sep 18, 2024
Reiterates: Buy
Price Target: $29
Current: $33.29
Upside: -12.89%
Sep 16, 2024
Maintains: Buy
Price Target: $8 → $7
Current: $2.68
Upside: +161.19%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $6.90
Upside: +59.42%
Aug 23, 2024
Reiterates: Buy
Price Target: $10
Current: $4.88
Upside: +104.92%
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.39
Upside: -
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $11.40
Upside: -
Aug 20, 2024
Reiterates: Buy
Price Target: $5
Current: $1.50
Upside: +233.33%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.96
Upside: +134.89%
Aug 15, 2024
Reiterates: Buy
Price Target: $12
Current: $0.84
Upside: +1,333.86%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $9.75
Upside: +1,951.28%
Apr 16, 2024
Reiterates: Buy
Price Target: $4
Current: $0.21
Upside: +1,804.76%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $1.36
Upside: +1,370.59%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.96
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $1.75
Upside: +8,495.99%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.55
Upside: +1,319.35%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.68
Upside: +316.67%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $1.09
Upside: +909.17%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $1.21
Upside: +18,495.04%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $5.08
Upside: +392.13%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $2.29
Upside: +467.69%